Pages that link to "Q38851907"

The following pages link to HDAC1 inhibition by melatonin leads to suppression of lung adenocarcinoma cells via induction of oxidative stress and activation of apoptotic pathways (Q38851907):

Displaying 44 items.

• Melatonin as a potential anticarcinogen for non-small-cell lung cancer (Q26751220) (← links)
• Inhibition of iron overload-induced apoptosis and necrosis of bone marrow mesenchymal stem cells by melatonin. (Q32178275) (← links)
• Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis (Q33624824) (← links)
• Effects of Melatonin and Its Analogues on Pancreatic Inflammation, Enzyme Secretion, and Tumorigenesis (Q33755141) (← links)
• Evaluation of cell death pathways initiated by antitumor drugs melatonin and valproic acid in bladder cancer cells. (Q33762681) (← links)
• Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models (Q33779673) (← links)
• Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation. (Q37330410) (← links)
• Melatonin enhances sensitivity to fluorouracil in oesophageal squamous cell carcinoma through inhibition of Erk and Akt pathway (Q37468639) (← links)
• Melatonin as pleiotropic molecule with therapeutic potential for type 2 diabetes and cancer. (Q38655441) (← links)
• Melatonin suppresses TPA-induced metastasis by downregulating matrix metalloproteinase-9 expression through JNK/SP-1 signaling in nasopharyngeal carcinoma (Q38737907) (← links)
• Melatonin promotes circadian rhythm-induced proliferation through Clock/histone deacetylase 3/c-Myc interaction in mouse adipose tissue (Q39092878) (← links)
• Novel Protective Role for Ubiquitin-Specific Protease 18 in Pathological Cardiac Remodeling (Q39443285) (← links)
• Pterostilbene exerts anticancer activity on non-small-cell lung cancer via activating endoplasmic reticulum stress. (Q41388371) (← links)
• Melatonin suppresses hepatocellular carcinoma progression via lncRNA-CPS1-IT-mediated HIF-1α inactivation. (Q45394478) (← links)
• Melatonin-Induced Changes in Cytosolic Calcium Might be Responsible for Apoptosis Induction in Tumour Cells. (Q46255324) (← links)
• Association of downregulated HDAC 2 with the impaired mitochondrial function and cytokine secretion in the monocytes/macrophages from gestational diabetes mellitus patients (Q46586323) (← links)
• Melatonin suppresses fibrotic responses induced by cigarette smoke via downregulation of TGF-β1. (Q47121001) (← links)
• Melatonin inhibits nucleus pulposus (NP) cell proliferation and extracellular matrix (ECM) remodeling via the melatonin membrane receptors mediated PI3K-Akt pathway (Q47272699) (← links)
• Melatonin: does it have utility in the treatment of haematological neoplasms? (Q47569519) (← links)
• Melatonin regulates PARP1 to control the senescence-associated secretory phenotype (SASP) in human fetal lung fibroblast cells (Q48181461) (← links)
• Mitochondrial cytochrome P450 (CYP) 1B1 is responsible for melatonin-induced apoptosis in neural cancer cells. (Q49907507) (← links)
• SIRT1 activation by pterostilbene attenuates the skeletal muscle oxidative stress injury and mitochondrial dysfunction induced by ischemia reperfusion injury. (Q51301800) (← links)
• Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21Waf1/Cip1 and p19INK4d upregulation in hepatocellular carcinoma. (Q51737822) (← links)
• Effects and mechanisms of melatonin on neural differentiation of induced pluripotent stem cells. (Q53111241) (← links)
• Radical-trapping and preventive antioxidant effects of 2-hydroxymelatonin and 4-hydroxymelatonin: Contributions to the melatonin protection against oxidative stress. (Q54053688) (← links)
• Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-κB DNA-binding activity. (Q54224159) (← links)
• Melatonin and its metabolite N1-acetyl-N2-formyl-5-methoxykynuramine (afmk) enhance chemosensitivity to gemcitabine in pancreatic carcinoma cells (PANC-1) (Q57301375) (← links)
• Promising Antineoplastic Actions of Melatonin (Q58554204) (← links)
• Melatonin May Increase Anticancer Potential of Pleiotropic Drugs (Q60912712) (← links)
• Melatonin and its metabolites vs oxidative stress: From individual actions to collective protection (Q62071826) (← links)
• Comprehensive Investigation of the Antioxidant and Pro-oxidant Effects of Phenolic Compounds: A Double-Edged Sword in the Context of Oxidative Stress? (Q62071829) (← links)
• Computational strategies for predicting free radical scavengers' protection against oxidative stress: Where are we and what might follow? (Q62071830) (← links)
• Role of purines on the copper-catalyzed oxidative damage in biological systems: Protection versus promotion (Q62071832) (← links)
• Melatonin and non-small cell lung cancer: new insights into signaling pathways (Q64053319) (← links)
• Melatonin's Antineoplastic Potential Against Glioblastoma (Q90073236) (← links)
• Melatonin reverses nasopharyngeal carcinoma cisplatin chemoresistance by inhibiting the Wnt/β-catenin signaling pathway (Q90588984) (← links)
• Inhibition of TFEB oligomerization by co-treatment of melatonin with vorinostat promotes the therapeutic sensitivity in glioblastoma and glioma stem cells (Q91069709) (← links)
• Detailed Investigation of the Outstanding Peroxyl Radical Scavenging Activity of Two Novel Amino-Pyridinol-Based Compounds (Q91545243) (← links)
• Melatonin in Medicinal and Food Plants: Occurrence, Bioavailability, and Health Potential for Humans (Q91714827) (← links)
• Prognostic Impact of Melatonin Receptors MT1 and MT2 in Non-Small Cell Lung Cancer (NSCLC) (Q91994960) (← links)
• PERK/eIF-2α/CHOP Pathway Dependent ROS Generation Mediates Butein-induced Non-small-cell Lung Cancer Apoptosis and G2/M Phase Arrest (Q92276481) (← links)
• Effects of miR-34b/miR-892a Upregulation and Inhibition of ABCB1/ABCB4 on Melatonin-Induced Apoptosis in VCR-Resistant Oral Cancer Cells (Q92945442) (← links)
• Melatonin synergizes BRAF-targeting agent dabrafenib for the treatment of anaplastic thyroid cancer by inhibiting AKT/hTERT signalling (Q99552853) (← links)
• Worldwide melatonin research: a bibliometric analysis of the published literature between 2015 and 2019 (Q101464357) (← links)